C4 Therapeutics (CCCC) Research & Development (2019 - 2025)
Historic Research & Development for C4 Therapeutics (CCCC) over the last 7 years, with Q3 2025 value amounting to $26.0 million.
- C4 Therapeutics' Research & Development fell 1837.11% to $26.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $105.5 million, marking a year-over-year increase of 351.21%. This contributed to the annual value of $110.6 million for FY2024, which is 600.56% down from last year.
- Per C4 Therapeutics' latest filing, its Research & Development stood at $26.0 million for Q3 2025, which was down 1837.11% from $26.2 million recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Research & Development registered a high of $32.5 million during Q4 2024, and its lowest value of $20.5 million during Q1 2021.
- Its 5-year average for Research & Development is $27.4 million, with a median of $27.1 million in 2025.
- Its Research & Development has fluctuated over the past 5 years, first soared by 3451.43% in 2022, then crashed by 2241.24% in 2024.
- Quarter analysis of 5 years shows C4 Therapeutics' Research & Development stood at $26.6 million in 2021, then rose by 15.45% to $30.7 million in 2022, then fell by 0.85% to $30.4 million in 2023, then increased by 6.98% to $32.5 million in 2024, then fell by 20.07% to $26.0 million in 2025.
- Its last three reported values are $26.0 million in Q3 2025, $26.2 million for Q2 2025, and $27.1 million during Q1 2025.